MP
LVACU

Mangrove Partners’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Mangrove Partners’s Portfolio LVACU Stock Details LVACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-400,000
Closed -$4.04M – 678
2022
Q1 		$4.04M Hold
400,000
– – 0.22% 170
2021
Q4 		$4.03M Buy
+400,000
New +$4.05M 0.24% 125

Other funds holding LVACU

CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Mangrove Partners's LVACU Position: Q2 2022 in Review

Mangrove Partners sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q2 2022, closing a stake of 400,000 shares — an estimated $4.04M sold.

Mangrove Partners first reported a position in LVACU in Q4 2021 and held it in 2 quarters. The position peaked at $4.04M in Q1 2022. 14 funds tracked by Wall St. Rank hold LVACU as of Q2 2022.

  • Mangrove Partners reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q2 2022 after selling out during the quarter.
  • Mangrove Partners sold 400,000 LAVA Medtech Acquisition Corp. Unit shares in Q2 2022, an estimated $4.04M.
  • Mangrove Partners first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 2 quarters.
  • Mangrove Partners's LAVA Medtech Acquisition Corp. Unit position peaked at $4.04M in Q1 2022.
  • 14 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q2 2022.

Based on Mangrove Partners's 13F filing for Q2 2022, filed 15 Aug 2022.